CoChat

C-Reactive Protein Levels Are Not Associated with Increased Risk for Colorectal Cancer in Women

Zhang, Shumin M., Buring, Julie E., Lee, I-Min, Cook, Nancy R., Ridker, Paul M. · 2005 · Annals of Internal Medicine
Cited by 115

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Observations that risk for colorectal cancer is elevated in patients with inflammatory bowel disease and that long-term use of anti-inflammatory drugs may reduce colorectal cancer risk have raised the possibility that inflammation may play a role in the development of colorectal cancer. While a recent prospective study observed a positive association between C-reactive protein (CRP), a marker of inflammation, and risk for colon cancer, data testing this hypothesis are sparse. OBJECTIVE: To evaluate whether plasma CRP levels predict colorectal cancer risk in women. DESIGN: Prospective cohort study, with 97% morbidity follow-up and 100% mortality follow-up within the past 2 years. SETTING: Women's Health Study. PARTICIPANTS: 27,913 apparently healthy women age 45 years or older who had CRP measured at entry into a trial of low-dose aspirin and vitamin E. Maximum length of intervention and follow-up was 10.8 years. MEASUREMENTS: Self-reported incident colorectal adenocarcinoma confirmed by medical record review. RESULTS: 169 women developed colorectal adenocarcinomas during follow-up. Baseline CRP levels were not significantly associated with colorectal cancer risk. The multivariate hazard ratios according to cutoff points for CRP proposed in clinical guidelines were 0.79 (95% CI, 0.53 to 1.17) for the category of 1 to 3 mg/L and 0.66 (CI, 0.43 to 1.03) for the category of greater than 3 mg/L (P for trend = 0.09), as compared with the category of less than 1 mg/L. High CRP levels were also not associated with increased risk in analyses done according to tumor location and stage at diagnosis, according to alternative cutoff points for CRP, or in any of the subgroups evaluated. LIMITATIONS: Despite multivariate analysis, residual confounding might still be present. Although this study was prospective, we cannot completely exclude undetected cancer at baseline. Measurements for CRP were available for only 71% of women in the cohort; however, the women who did and those who did not provide blood were mostly similar. CONCLUSIONS: Plasma CRP levels do not appear to predict an increased risk for developing colorectal cancer in apparently healthy women. Low-grade inflammation may not play an important role in increasing the risk for colorectal cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.7326/0003-4819-142-6-200503150-00008

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 115

Metadata

Authors
Zhang, S. M., Buring, J. E., Lee, I.-M., Cook, N. R., & Ridker, P. M.
Venue
Annals of Internal Medicine
Published
2005-03-15
Volume
142
Issue
6
Pages
425-432
ISSN
  • 0003-4819 (ISSN-L)
  • 1539-3704
OpenAlex
W2046072702
Cited by
115
References
8
FWCI
5.09
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: C-Reactive Protein Levels Are Not Associated with Increased Risk for Colorectal Cancer in Women. https://app.cochat.ai/papers/10.7326/0003-4819-142-6-200503150-00008
The paper
Zhang, S. M., Buring, J. E., Lee, I.-M., Cook, N. R., & Ridker, P. M. (2005). C-Reactive Protein Levels Are Not Associated with Increased Risk for Colorectal Cancer in Women. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-142-6-200503150-00008

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.